Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
The American Journal of Drug and Alcohol Abuse|April 28, 2021
Common themes in early state policy responses to substance use disorder treatment during COVID-19Barbara Andraka-Christou, Kathryn Bouskill, Rebecca L Haffajee, et al.
Health Communication|June 30, 2025
Analyzing the Discursive Framing of Medications for Opioid Use Disorder (MOUDs) in U.S. News Media: A Comparative Study of Benefits, Persuasion Methods, and Temporal TrendsFatema Z Ahmed, Olivia K Golan, Rachel Totaram, et al.
Health & Justice|December 19, 2024
The effects of message framing on US police chiefs' support for interventions for opioid use disorder: a randomized survey experimentBrandon Del Pozo, Saba Rouhani, Amelia Bailey, et al.
Journal of Addictive Diseases|August 21, 2023
Operationalizing person-centered care in residential substance use disorder treatmentBarbara Andraka-Christou, Olivia K Golan, Rachel Totaram, et al.
Substance Abuse Treatment, Prevention, and Policy|July 17, 2023
Key person-centered care domains for residential substance use disorder treatment facilities: former clients' perspectivesBarbara Andraka-Christou, Danielle N Atkins, Morgan C Shields, et al.
Drug and Alcohol Dependence|September 21, 2023
How are state telehealth policies associated with services offered by substance use disorder treatment facilities? Evidence from 2019 to 2022Denis Agniel, Jonathan Cantor, Olivia K Golan, et al.
Pain Medicine (Malden, Mass.)|August 8, 2023
Urine drug testing in the context of opioid analgesic prescribing for chronic pain: a content analysis of U.S. state laws in 2022Barbara Andraka-Christou, Elizabeth McAvoy, Adam J Gordon, et al.
Drug and Alcohol Dependence|April 17, 2022
Systematic review and meta-analysis of changes in quality of life following initiation of buprenorphine for opioid use disorderOlivia K Golan, Rachel Totaram, Elizabeth Perry, et al.
Drug and Alcohol Dependence Reports|October 25, 2023
Differences in medicaid expansion effects on buprenorphine treatment utilization by county rurality and income: A pharmacy data claims analysis from 2009-2018Olivia K Golan, Flora Sheng, Andrew W Dick, et al.
Substance Use & Addiction Journal|December 4, 2024
Medication for Opioid Use Disorders (MOUD) Providers' Experiences with Recovery Courts: Qualitative Study of Individual and Systemic Factors Impacting Interagency CollaborationEkaterina Pivovarova, Faye S Taxman, Alexandra K Boland, et al.
Pageof 8